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The escalating global pandemic of tuberculosis infections
results in 8 million new cases diagnosed each year.1-4 Two
billion people (or a third of the of the world’s population)
have been or are currently infected with tuberculosis.
The prevalence of HIV results in a high incidence of
musculoskeletal tuberculosis, of which 60% affects the
skeleton, and in 50% the spine1,4-6 with the thoracic and thora-
columbar areas most commonly affected (Figure 1). This
often results in deformity with associated neurological
compromise, requiring extended in-patient treatment and
rehabilitation. 
Tissue diagnosis and antimicrobial sensitivity is crucial
given the increased prevalence of extreme drug-resistant
(XDR) and multidrug-resistant (MDR) tuberculosis1
reported in up to 12% of cases in South Africa.2,7
Percutaneous needle biopsy does not decompress the
spinal canal, and neurologic recovery is dependent on
medical treatment alone. Costotransversectomy is a
relatively simple procedure that yields a good tissue sample
while indirectly decompressing the spinal canal simultane-
ously, theoretically leading to earlier neurological recovery. 
A potential concern however, is the structural integrity of
the spinal column, and the possible adverse effect on spinal
stability of the removal of the transverse process, underlying
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rib-head and costovertebral joint resulting in a greater end
deformity.
We present a series of 30 patients who underwent costo-
transversectomy for thoracic spinal tuberculosis with a
predicted final kyphosis less than 70°.
Materials and methods
A retrospective case note and radiological record review was
performed of all patients treated during the period from 
1 January 2010 to 30 June 2012 at Tygerberg Hospital,
presenting with suspected thoracic or thoracolumbar spinal
tuberculosis, and in whom the final predicted deformity was
less than 70° kyphosis. All patients with records included in
our cohort underwent an indirect decompression and
biopsy through costotransversectomy. 
The records of the patients included were reviewed for
demographic data, HIV status, neurological status and
initial spinal deformity.
At the 6 months post-operative mark, the neurological
status of the patient was re-assessed and compared to the
neurologic status pre-operatively. 
One year post-operatively, the deformity was assessed and
compared to the final deformity predicted by Rajasekaran’s
equation as calculated from the presenting standing plain-
film radiographs.8
Thirty patients were included in the study, 16 male and 14
female. The average age was 37 years (6–67 years ± 15).
Fifteen patients were HIV positive with an average CD4
count of 235 (10–500 ± 157). 
Ten of these patients were on highly active anti-retroviral
therapy (HAART). Average ESR was 70 (12–125 ± 33) pre-
surgery, and improved on average to 28 at one year post-
operatively (10–53 ± 12). Polymerase chain reaction (PCR)
testing was not performed on all of these patients.
Results
The average pre-operative Frankel grade was C, with 17
patients having a Frankel grade A, B or C, equating to a non-
ambulatory patient requiring prolonged in-patient
treatment and extensive rehabilitation. Thirteen patients
were independently mobile. 
At 6 months post-operatively the average Frankel grade
improved to a grade D, with only six patients still rated as
Frankel Grade A, B or C. The remaining 24 patients were
independently mobile with Frankel Grades of D or E, and no
longer required in-patient treatment. This improvement was
statistically significant (p = 0.01) (Table I). The neurological
recovery of the HIV-positive and MDR-TB group was not
statistically different from the HIV-negative group.
Tissue cultures were positive in 20 patients after 22.9 days
(67% yield) (range 13–47 ± 9.5). Three patients (10%)
cultured multidrug-resistant tuberculosis. The demon-
strated yield proved superior to percutaneous needle
biopsies performed at the same institution for the same time
period, with a positive culture yield of 56% reported.2
Initial radiographical analysis revealed an average
kyphotic deformity of 18.7° (range 4–37° ± 9). Rajasekaran’s
equation of Y = 5.5° + 30.5x, where Y is the final predicted
deformity and x the amount of vertebral body involved in
tenths, was used to predict the final deformity.8 The average
amount of vertebral body involved was 0.65, giving a
predicted end deformity of 25.6° ± 11.5 in the sagittal plane.
The sagittal deformity one year post-operatively was 
26° ± 10.2° (Table II). This was not significantly different from
the final predicted kyphosis.
The initial coronal deformity was on average 3.7° (range
0–19° ± 4.9) and at one year follow-up the average was 
4.2° ± 5.2°. 
No complications were encountered in this series.
table i: Frankel Grade of neurological involvement














SA Orthopaedic Journal  Autumn 2016 | Vol 15 • No 1 Page 85
Discussion
In 2010 there were globally 8.8 million new cases of TB
diagnosis, in part due to the prevalence of HIV.9,10 Cases with
multi- and extreme drug-resistant tuberculosis make
bacterial culture and antimicrobial sensitivity mandatory
before initiating treatment.
Neurological deficit can be as high as 41%, especially when
it occurs in the thoracic or thoracolumbar area.1,4,6,9,11 Many of
these patients are bed-bound due to paraplegia, requiring
prolonged in-hospital stay and extended rehabilitation at an
appropriate facility. This places an additional burden on an
already strained health care system.
Much has been written about the treatment and surgical
management of spinal tuberculosis.6,10,12-18 Hodgkin and
Stock advocated aggressive surgical debridement of all 
tuberculous lesions in the spine.17 They advocated that
anti-tuberculous chemotherapy did not penetrate the
osseous anatomy adequately, and only surgical
debridement removed the necrotic tissue. Tuli advocated
the ‘middle-path’ regimen, where medical treatment is the
cornerstone of treatment and surgery is only advocated for
selected cases.18
The Medical Research Council’s (MRC) Working Party on
spinal tuberculosis showed that medical management of
spinal tuberculosis should be the cornerstone of treatment.19-22
The MRC’s 15-year follow-up report states that 87% of the
study patients attained a favourable status (defined as: no
evidence of CNS involvement, no sinus or clinically evident
abscess, radiological quiescence of the disease and no
restriction of physical activity), regardless of surgical
treatment modality.20
It is evident from the MRC’s research that radical
debridement and reconstruction should be reserved for
select cases due to the resource-intensive nature of these
procedures. Reconstruction should be reserved for cases
with a predicted end deformity greater than 70°, continued
neurologic deterioration or instability.
Although neurological recovery happens with
chemotherapy alone, there is very little literature available
regarding the time it takes a patient to achieve mobility to
such a degree that they can be managed as an outpatient. 
Tissue diagnosis and testing for resistance is mandatory
given the incidence of MDR and XDR TB.7 Currently percu-
taneous transpedicular needle is still the most commonly
used modality to obtain tissue for microscopy, culture and
sensitivity (MCS). No decompression of the spinal cord is
performed either directly or indirectly, and neurological
recovery is dependent on chemotherapy alone. Our study
group had a 67% yield for positive culture, with reported
yields from needle biopsies ranging from 42–76%.7,23,24
The current policy at Tygerberg Hospital’s spinal unit is to
perform a costotransversectomy for patients with suspected
thoracic spinal tuberculosis with a predicted end deformity
of less than 70°. It is a relatively simple procedure that yields
a good amount of tissue under direct vision, as well as a
resultant indirect decompression of the spinal cord.
Patients are positioned prone on a Relton-Hall frame in the
same position as for a percutaneous transpedicular needle
biopsy. The correct level is identified with fluoroscopy, and a
midline incision is made. The costovertebral junction is then
identified, the transverse process and the underlying rib
head is resected towards the tubercle of the rib. Following
removal of the rib head, the periosteum is then elevated
from the vertebral body while staying extra-pleural until pus
or necrotic material is encountered.
An adequate specimen can then be sampled under direct
vision, and the spinal cord is decompressed indirectly by
means of decompressing the abscess cavity and allowing
pus to drain from the spinal canal.
We were able to demonstrate that 80% (24 patients) of
our patients were ambulatory 6 months post-operatively
versus 43% (13 patients) pre-operatively. This finding was
statistically significant, p=0.01. The ambulatory patients
did not require any in-patient treatment at a rehabilitation
facility. 
Our 67% positive culture on specimens compared
favourably to national and international standards as
mentioned earlier.2 Costotransversectomy compared
favourably to the 56% yield of needle biopsies performed at
the same institution for suspected thoracolumbar and
lumbar spinal tuberculosis.2 This was attributed to the
processing of the samples at the laboratory where all
specimens were decontaminated before culture and
microscopy.
Removal of the rib head has been postulated to decrease
the stability of the spinal column which would in turn
increase the deformity. Our study shows that when
compared to the final predicted sagittal deformity as per
Rajasekaran’s equation, there was no statistically significant
increase in the sagittal deformity.8
In summary, costotransversectomy provides indirect
decompression of the thoracic spinal canal possibly leading
to earlier neurological recovery and a decreased need for in-
patient treatment. The yield with regard to microbiological
diagnosis obtained is acceptable when compared to interna-
tional literature. Using Rajasekaran’s equation we also
showed that removing the rib head does not worsen, or
improve the deformity.
Costotransversectomy for thoracic spinal tuberculosis is an
effective treatment option in thoracic spinal tuberculosis,
both in establishing diagnosis and appropriate treatment
sensitivities, as well as the additional benefit of potentially
earlier neurological recovery.
Conclusion
Indirect decompression via costotransversectomy provides a
simple option for cord decompression and simultaneous
confirmation of diagnosis and sensitivity to anti-microbials,
in the sub-group of patients with an acceptable predicted
end deformity. A statistically significant improvement could
be demonstrated at six months (p=0.01) with regard to
neurological deficit.
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No detrimental effect could be shown in progression of
spinal deformity.
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